Don't we forget about biological therapy of hypercholesterolemia with PCSK9-inhibitors?
{{output}}
In many patients it is difficult to achieve the current very low target LDL-cholesterol levels, recommended for the prevention of atherosclerotic cardiovascular events. If statin therapy or statins in combination with ezetimibe are not sufficient, addition of ... ...